
    
      Treatment Strategy: Multicentric, parallel double blind randomized phase 2 prospective study
      comparing MTX taken orally once a week + narrowband UVB TL01 versus placebo + narrowband UVB
      TL01 Follow-up of the study: patients included in this study will start MTX 2 months before
      starting narrowband UVB TL01. Phototherapy will be performed twice a week during 6 months.
      Follow-up visit will be done at month 2, 4 and month 8. Phone calls to the patient will be
      done at month 6
    
  